| __timestamp | Iovance Biotherapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 22223073 |
| Thursday, January 1, 2015 | 15470000 | 6966842 |
| Friday, January 1, 2016 | 28037000 | 9000499 |
| Sunday, January 1, 2017 | 71615000 | 13741186 |
| Monday, January 1, 2018 | 99828000 | 19040000 |
| Tuesday, January 1, 2019 | 166023000 | 23559000 |
| Wednesday, January 1, 2020 | 201727000 | 31931000 |
| Friday, January 1, 2021 | 259039000 | 44981000 |
| Saturday, January 1, 2022 | 294781000 | 54234000 |
| Sunday, January 1, 2023 | 344077000 | 63806000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Iovance Biotherapeutics, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. Since 2014, Iovance has consistently increased its R&D budget, culminating in a staggering 12,600% rise by 2023. This aggressive investment reflects their focus on pioneering cancer immunotherapies. Meanwhile, Viking Therapeutics has adopted a more measured approach, with a 187% increase in R&D spending over the same period, emphasizing their strategic focus on metabolic and endocrine disorders. This divergence in financial allocation underscores the distinct paths these companies are taking in the biotech landscape. As we look to the future, these investment trends may well dictate their respective positions in the market.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.